Last update 11 Apr 2025

Vixarelimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Immunoglobulin g (234-proline,303-glutamine), anti-(human oncostatin m receptor subunit .beta.) (human monoclonal kpl-716 .gamma.-chain), disulfide with human monoclonal kpl-716 .lambda.-chain, dimer, KPL 716, KPL-716
+ [1]
Target
Action
inhibitors
Mechanism
OSMRβ inhibitors(oncostatin M receptor inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationBreakthrough Therapy (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colitis, UlcerativePhase 2
Argentina
13 Mar 2024
Colitis, UlcerativePhase 2
Argentina
13 Mar 2024
Idiopathic Pulmonary FibrosisPhase 2
United States
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Argentina
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Australia
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Belgium
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Brazil
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Canada
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
Chile
26 May 2023
Idiopathic Pulmonary FibrosisPhase 2
France
26 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
40
ltqewokhvn(gjqiymhgtl) = ubivmkxzlf ntzolkmxxn (dqgumfochs )
Positive
01 Mar 2023
Placebo
ltqewokhvn(gjqiymhgtl) = gkwizppebu ntzolkmxxn (dqgumfochs )
Phase 2
49
horckqajah(gfddiysonb) = bdiyqicwth ilxxzikews (tqunrksfkr )
Positive
22 Apr 2020
Placebo
horckqajah(gfddiysonb) = dvarkfgmdc ilxxzikews (tqunrksfkr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free